Literature DB >> 17347363

Maternal depression and psychotropic medication effects on the human fetus.

Eugene K Emory1, John N I Dieter.   

Abstract

Ultrasound studies examined fetuses of depressed and nondepressed mothers. Fetuses of depressed mothers were more active during mid-gestation and exhibited lower baseline heart rate and moved less during late-term vibratory stimulation. Mid-gestation heightened activity and late-term diminished responsivity may be a prenatal manifestation of the "general adaptation syndrome." Color Doppler technology measured blood flow velocity in the middle cerebral artery of fetuses whose mothers were prescribed SSRIs or lithium. SSRIs were associated with velocity increases and lithium with velocity decreases. The effects of psychotropic medications on prenatal neurobehavioral development require further study to document potential benefits and adverse effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17347363     DOI: 10.1196/annals.1376.036

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

Review 1.  Prenatal depression effects and interventions: a review.

Authors:  Tiffany Field; Miguel Diego; Maria Hernandez-Reif
Journal:  Infant Behav Dev       Date:  2010-05-14

Review 2.  Linking prenatal maternal adversity to developmental outcomes in infants: the role of epigenetic pathways.

Authors:  Catherine Monk; Julie Spicer; Frances A Champagne
Journal:  Dev Psychopathol       Date:  2012-11

Review 3.  Maternal Affective Illness in the Perinatal Period and Child Development: Findings on Developmental Timing, Mechanisms, and Intervention.

Authors:  Thomas G O'Connor; Catherine Monk; Anne S Burke
Journal:  Curr Psychiatry Rep       Date:  2016-03       Impact factor: 5.285

Review 4.  Antenatal depression and children's developmental outcomes: potential mechanisms and treatment options.

Authors:  Cerith S Waters; Dale F Hay; Jessica R Simmonds; Stephanie H M van Goozen
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-07-19       Impact factor: 4.785

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.